Mark E Linskey
Overview
Explore the profile of Mark E Linskey including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
77
Citations
2139
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Xu J, Haider S, Sharma A, Blumenfeld K, Cheng J, Mazzola C, et al.
World Neurosurg
. 2022 Oct;
168:e328-e335.
PMID: 36202339
Objective: Telehealth was rapidly adopted during the COVID-19 pandemic. A survey was distributed to neurosurgeons in the United States (U.S.) to understand its use within neurosurgery, what barriers exist, unique...
2.
Martin E, Bitner B, Perez-Rosendahl M, Kuan E, Linskey M
Neuropathology
. 2022 Feb;
42(2):155-159.
PMID: 35137463
Pituitary adenoma is one of the three most common neoplasms described in multiple endocrine neoplasia type 1 (MEN1), and patients with pituitary adenoma occupies 30-50% of those with MEN1-related tumor....
3.
Agarwal N, Casillo S, Simonds G, Wakefield A, Phelps J, Linskey M, et al.
World Neurosurg
. 2021 Jul;
151:353-363.
PMID: 34243669
No physician can successfully deliver high-value patient care in the modern-day health care system in isolation. Delivery of effective patient care requires integrated and collaborative systems that depend on dynamic...
4.
Afrasiabi K, Linskey M, Zhou Y
Cancers (Basel)
. 2020 Jun;
12(6).
PMID: 32580319
The history of modern oncology started around eighty years ago with the introduction of cytotoxic agents such as nitrogen mustard into the clinic, followed by multi-agent chemotherapy protocols. Early success...
5.
Ke C, Luo J, Cen Z, Li Y, Cai H, Wang J, et al.
Cancer Sci
. 2020 Jan;
111(3):940-950.
PMID: 31922633
The ECM protein EFEMP1 (fibulin-3) is associated with all types of solid tumor through its cell context-dependent dual function. A variant of fibulin-3 was engineered by truncation and mutation to...
6.
Choy J, Abouzari M, Mahboubi H, Linskey M, Djalilian H
Ear Nose Throat J
. 2019 Apr;
98(9):537-539.
PMID: 30955377
No abstract available.
7.
Elder J, Nahed B, Linskey M, Olson J
Neurosurgery
. 2019 Jan;
84(3):E201-E203.
PMID: 30629215
Question: What evidence is available regarding emerging and investigational treatment options for metastatic brain tumors? Target Population: Adult patients with brain metastases. Recommendations: Interstitial Modalities: There is insufficient evidence to...
8.
Rogers C, Simonds G, Mayo D, Linskey M, Phelps J
Neurosurgery
. 2018 Dec;
84(3):E225-E229.
PMID: 30535400
No abstract available.
9.
Li Y, Hu Y, Liu C, Wang Q, Han X, Han Y, et al.
Oncotarget
. 2018 Jan;
8(63):106311-106323.
PMID: 29290950
Background: Decades of cytotoxic and more recently immunotherapy treatments for malignant glioma have had limited success due to dynamic intra-tumoral heterogeneity. The dynamic interplay of cancer cell subpopulations has been...
10.
Trinh A, Chen H, Chen Y, Hu Y, Li Z, Siegel E, et al.
Cancers (Basel)
. 2017 Dec;
9(12).
PMID: 29211022
Intra-tumoral heterogeneity is associated with therapeutic resistance of cancer and there exists a need to non-invasively identify functional tumor subpopulations responsible for tumor recurrence. Reduced nicotinamide adenine dinucleotide (NADH) is...